Bloomberg reports the South African pharmacy chain is seeing sales gains tied to demand for GLP-1 drugs.
Recap by typeshit. Full story at Bloomberg.com.
Novo reports nine-month results on Nov. 4, after a US judge declined its request to pause Lilly's weight-loss drug ads while the marketing dispute continues.
The Urban Zakapa singer shared gym-bound photos captioned with a call to go work out, as she focuses on exercise to hold her weight after stopping Wegovy.
The fitness creator argues people chase shortcuts and should handle walking, tracking food, water and 7 to 9 hours of sleep before adding peptides.
The Wegovy-sponsored CFL Division Finals kick off November 7 at 3:00 PM ET, the next step on the road to the Grey Cup.
A new market report values the sector at $97.5 billion in 2025 and expects oral and multi-pathway drugs to grow fastest as Medicare coverage starts in mid-2026.
Retrospective REDEFINE 1 analyses in 2,309 women showed 25.0% average weight loss on CagriSema at 68 weeks, per Novo, versus 3.0% on placebo.
Loading…